Skip to main content
Top
Published in: BMC Gastroenterology 1/2018

Open Access 01-12-2018 | Research article

Risk factor for steatorrhea in pediatric chronic pancreatitis patients

Authors: Lu Hao, Teng Wang, Lin He, Ya-Wei Bi, Di Zhang, Xiang-Peng Zeng, Lei Xin, Jun Pan, Dan Wang, Jun-Tao Ji, Ting-Ting Du, Jin-Huan Lin, Li-Sheng Wang, Wen-Bin Zou, Hui Chen, Ting Xie, Hong-Lei Guo, Bai-Rong Li, Zhuan Liao, Zheng-Lei Xu, Zhao-Shen Li, Liang-Hao Hu

Published in: BMC Gastroenterology | Issue 1/2018

Login to get access

Abstract

Background

Pediatric patients always suffer from chronic pancreatitis (CP), especially those with steatorrhea. This study aimed to identify the incidence of and risk factors for steatorrhea in pediatric CP. To our best knowledge, there is no pediatric study to document the natural history of steatorrhea in CP.

Methods

CP patients admitted to our center from January 2000 to December 2013 were enrolled. Patients were assigned to the pediatric (< 18 years old) and adult group according to their age at onset of CP. Cumulative rates of steatorrhea in both groups were calculated. Risk factors for both groups were identified, respectively.

Results

The median follow-up duration for the whole cohort was 7.6 years. In a total of 2153 patients, 13.5% of them were pediatrics. The mean age at the onset and the diagnosis of CP in pediatrics were 11.622 and 19.727, respectively. Steatorrhea was detected in 46 patients (46/291, 15.8%) in the pediatric group and in 447 patients (447/1862, 24.0%) in the adult group. Age at the onset of CP (hazard ratio [HR], 1.121), diabetes mellitus (DM, HR, 51.140), and severe acute pancreatitis (SAP, HR, 13.946) was identified risk factor for steatorrhea in the pediatric group.

Conclusions

Age at the onset of CP, DM and SAP were identified risk factors for the development of steatorrhea in pediatric CP patients. The high-risk populations were suggested to be followed up closely. They may benefit from a full adequate pancreatic exocrine replacement therapy.
Literature
1.
go back to reference Yadav D, Timmons L, Benson JT, Dierkhising RA, Chari ST. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol. 2011;106:2192–9.CrossRefPubMed Yadav D, Timmons L, Benson JT, Dierkhising RA, Chari ST. Incidence, prevalence, and survival of chronic pancreatitis: a population-based study. Am J Gastroenterol. 2011;106:2192–9.CrossRefPubMed
2.
go back to reference Spanier B, Bruno MJ, Dijkgraaf MG. Incidence and mortality of acute and chronic pancreatitis in the Netherlands: a nationwide record-linked cohort study for the years 1995-2005. World J Gastroenterol. 2013;19:3018–26.CrossRefPubMedPubMedCentral Spanier B, Bruno MJ, Dijkgraaf MG. Incidence and mortality of acute and chronic pancreatitis in the Netherlands: a nationwide record-linked cohort study for the years 1995-2005. World J Gastroenterol. 2013;19:3018–26.CrossRefPubMedPubMedCentral
3.
go back to reference Hirota M, Shimosegawa T, Masamune A, Kikuta K, Kume K, Hamada S, Kihara Y, Satoh A, Kimura K, Tsuji I, Kuriyama S. The sixth nationwide epidemiological survey of chronic pancreatitis in Japan. Pancreatology. 2012;12:79–84.CrossRefPubMed Hirota M, Shimosegawa T, Masamune A, Kikuta K, Kume K, Hamada S, Kihara Y, Satoh A, Kimura K, Tsuji I, Kuriyama S. The sixth nationwide epidemiological survey of chronic pancreatitis in Japan. Pancreatology. 2012;12:79–84.CrossRefPubMed
4.
5.
go back to reference Dominguez-Munoz JE, Iglesias-Garcia J, Vilarino-Insua M, Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2007;5:484–8.CrossRefPubMed Dominguez-Munoz JE, Iglesias-Garcia J, Vilarino-Insua M, Iglesias-Rey M. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2007;5:484–8.CrossRefPubMed
6.
go back to reference Dominguez-Munoz JE, Iglesias-Garcia J. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy? JOP. 2010;11:158–62.PubMed Dominguez-Munoz JE, Iglesias-Garcia J. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy? JOP. 2010;11:158–62.PubMed
7.
go back to reference Pongprasobchai S. Maldigestion from pancreatic exocrine insufficiency. J Gastroenterol Hepatol. 2013;28(Suppl 4):99–102.CrossRefPubMed Pongprasobchai S. Maldigestion from pancreatic exocrine insufficiency. J Gastroenterol Hepatol. 2013;28(Suppl 4):99–102.CrossRefPubMed
8.
go back to reference Montalto G, Soresi M, Carroccio A, Scafidi E, Barbagallo CM, Ippolito S, Notarbartolo A. Lipoproteins and chronic pancreatitis. Pancreas. 1994;9:137–8.CrossRefPubMed Montalto G, Soresi M, Carroccio A, Scafidi E, Barbagallo CM, Ippolito S, Notarbartolo A. Lipoproteins and chronic pancreatitis. Pancreas. 1994;9:137–8.CrossRefPubMed
9.
go back to reference Tignor AS, Wu BU, Whitlock TL, Lopez R, Repas K, Banks PA, Conwell D. High prevalence of low-trauma fracture in chronic pancreatitis. Am J Gastroenterol. 2010;105:2680–6.CrossRefPubMed Tignor AS, Wu BU, Whitlock TL, Lopez R, Repas K, Banks PA, Conwell D. High prevalence of low-trauma fracture in chronic pancreatitis. Am J Gastroenterol. 2010;105:2680–6.CrossRefPubMed
10.
go back to reference Wang D, Bi Y-W, Ji J-T, Xin L, Pan J, Liao Z, Du T-T, Lin J-H, Zhang D, Zeng X-P, et al. Extracorporeal shock wave lithotripsy is safe and effective for pediatric patients with chronic pancreatitis. Endoscopy. 2017;49:447–55.CrossRefPubMed Wang D, Bi Y-W, Ji J-T, Xin L, Pan J, Liao Z, Du T-T, Lin J-H, Zhang D, Zeng X-P, et al. Extracorporeal shock wave lithotripsy is safe and effective for pediatric patients with chronic pancreatitis. Endoscopy. 2017;49:447–55.CrossRefPubMed
11.
go back to reference Schwarzenberg SJ, Bellin M, Husain SZ, Ahuja M, Barth B, Davis H, Durie PR, Fishman DS, Freedman SD, Gariepy CE, et al. Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden. J Pediatr. 2015;166:890–6 e891.CrossRefPubMed Schwarzenberg SJ, Bellin M, Husain SZ, Ahuja M, Barth B, Davis H, Durie PR, Fishman DS, Freedman SD, Gariepy CE, et al. Pediatric chronic pancreatitis is associated with genetic risk factors and substantial disease burden. J Pediatr. 2015;166:890–6 e891.CrossRefPubMed
12.
go back to reference Li BR, Pan J, Du TT, Liao Z, Ye B, Zou WB, Chen H, Ji JT, Zheng ZH, Wang D, et al. Risk factors for steatorrhea in chronic pancreatitis: a cohort of 2,153 patients. Sci Rep. 2016;6:21381.CrossRefPubMedPubMedCentral Li BR, Pan J, Du TT, Liao Z, Ye B, Zou WB, Chen H, Ji JT, Zheng ZH, Wang D, et al. Risk factors for steatorrhea in chronic pancreatitis: a cohort of 2,153 patients. Sci Rep. 2016;6:21381.CrossRefPubMedPubMedCentral
13.
go back to reference Toouli J, Biankin AV, Oliver MR, Pearce CB, Wilson JS, Wray NH, Australasian Pancreatic C. Management of pancreatic exocrine insufficiency: Australasian pancreatic Club recommendations. Med J Aust. 2010;193:461–7.PubMed Toouli J, Biankin AV, Oliver MR, Pearce CB, Wilson JS, Wray NH, Australasian Pancreatic C. Management of pancreatic exocrine insufficiency: Australasian pancreatic Club recommendations. Med J Aust. 2010;193:461–7.PubMed
14.
go back to reference Wang W, Liao Z, Li ZS, Shi XG, Wang LW, Liu F, Wu RP, Zheng JM. Chronic pancreatitis in Chinese children: etiology, clinical presentation and imaging diagnosis. J Gastroenterol Hepatol. 2009;24:1862–8.CrossRefPubMed Wang W, Liao Z, Li ZS, Shi XG, Wang LW, Liu F, Wu RP, Zheng JM. Chronic pancreatitis in Chinese children: etiology, clinical presentation and imaging diagnosis. J Gastroenterol Hepatol. 2009;24:1862–8.CrossRefPubMed
15.
go back to reference Li ZS, Wang W, Liao Z, Zou DW, Jin ZD, Chen J, Wu RP, Liu F, Wang LW, Shi XG, et al. A long-term follow-up study on endoscopic management of children and adolescents with chronic pancreatitis. Am J Gastroenterol. 2010;105:1884–92.CrossRefPubMed Li ZS, Wang W, Liao Z, Zou DW, Jin ZD, Chen J, Wu RP, Liu F, Wang LW, Shi XG, et al. A long-term follow-up study on endoscopic management of children and adolescents with chronic pancreatitis. Am J Gastroenterol. 2010;105:1884–92.CrossRefPubMed
16.
go back to reference Wang W, Liao Z, Li G, Li ZS, Chen J, Zhan XB, Wang LW, Liu F, Hu LH, Guo Y, et al. Incidence of pancreatic cancer in chinese patients with chronic pancreatitis. Pancreatology. 2011;11:16–23.CrossRefPubMed Wang W, Liao Z, Li G, Li ZS, Chen J, Zhan XB, Wang LW, Liu F, Hu LH, Guo Y, et al. Incidence of pancreatic cancer in chinese patients with chronic pancreatitis. Pancreatology. 2011;11:16–23.CrossRefPubMed
17.
go back to reference Wang W, Guo Y, Liao Z, Zou DW, Jin ZD, Zou DJ, Jin G, Hu XG, Li ZS. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas. 2011;40:206–12.CrossRefPubMed Wang W, Guo Y, Liao Z, Zou DW, Jin ZD, Zou DJ, Jin G, Hu XG, Li ZS. Occurrence of and risk factors for diabetes mellitus in Chinese patients with chronic pancreatitis. Pancreas. 2011;40:206–12.CrossRefPubMed
18.
go back to reference Xin L, He YX, Zhu XF, Zhang QH, Hu LH, Zou DW, Jin ZD, Chang XJ, Zheng JM, Zuo CJ, et al. Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients. Hepatobiliary Pancreat Dis Int. 2014;13:642–8.CrossRefPubMed Xin L, He YX, Zhu XF, Zhang QH, Hu LH, Zou DW, Jin ZD, Chang XJ, Zheng JM, Zuo CJ, et al. Diagnosis and treatment of autoimmune pancreatitis: experience with 100 patients. Hepatobiliary Pancreat Dis Int. 2014;13:642–8.CrossRefPubMed
19.
go back to reference Pan J, Xin L, Wang D, Liao Z, Lin JH, Li BR, Du TT, Ye B, Zou WB, Chen H, et al. Risk factors for diabetes mellitus in chronic pancreatitis: a cohort of 2011 patients. Medicine (Baltimore). 2016;95:e3251.CrossRef Pan J, Xin L, Wang D, Liao Z, Lin JH, Li BR, Du TT, Ye B, Zou WB, Chen H, et al. Risk factors for diabetes mellitus in chronic pancreatitis: a cohort of 2011 patients. Medicine (Baltimore). 2016;95:e3251.CrossRef
20.
go back to reference Yang YG, Hu LH, Chen H, Li B, Fan XH, Li JB, Wang JF, Deng XM. Target-controlled infusion of remifentanil with or without flurbiprofen axetil in sedation for extracorporeal shock wave lithotripsy of pancreatic stones: a prospective, open-label, randomized controlled trial. BMC Anesthesiol. 2015;15:161.CrossRefPubMedPubMedCentral Yang YG, Hu LH, Chen H, Li B, Fan XH, Li JB, Wang JF, Deng XM. Target-controlled infusion of remifentanil with or without flurbiprofen axetil in sedation for extracorporeal shock wave lithotripsy of pancreatic stones: a prospective, open-label, randomized controlled trial. BMC Anesthesiol. 2015;15:161.CrossRefPubMedPubMedCentral
21.
go back to reference Hao L, Pan J, Wang D, Bi YW, Ji JT, Xin L, Liao Z, Du TT, Lin JH, Zhang D, et al. Risk factors and nomogram for pancreatic pseudocysts in chronic pancreatitis: a cohort of 1998 patients. J Gastroenterol Hepatol. 2017;32:1403–11.CrossRefPubMed Hao L, Pan J, Wang D, Bi YW, Ji JT, Xin L, Liao Z, Du TT, Lin JH, Zhang D, et al. Risk factors and nomogram for pancreatic pseudocysts in chronic pancreatitis: a cohort of 1998 patients. J Gastroenterol Hepatol. 2017;32:1403–11.CrossRefPubMed
23.
go back to reference Hao L, Zeng XP, Xin L, Wang D, Pan J, Bi YW, Ji JT, Du TT, Lin JH, Zhang D, et al. Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: a cohort of 1656 patients. Dig Liver Dis. 2017;49(11):1249–56.CrossRefPubMed Hao L, Zeng XP, Xin L, Wang D, Pan J, Bi YW, Ji JT, Du TT, Lin JH, Zhang D, et al. Incidence of and risk factors for pancreatic cancer in chronic pancreatitis: a cohort of 1656 patients. Dig Liver Dis. 2017;49(11):1249–56.CrossRefPubMed
24.
go back to reference Li BR, Hu LH, Li ZS. Chronic pancreatitis and pancreatic cancer. Gastroenterology. 2014;147:541–2.CrossRefPubMed Li BR, Hu LH, Li ZS. Chronic pancreatitis and pancreatic cancer. Gastroenterology. 2014;147:541–2.CrossRefPubMed
25.
go back to reference Malde DJ, Oliveira-Cunha M, Smith AM. Pancreatic carcinoma masquerading as groove pancreatitis: case report and review of literature. Jop. 2011;12:598–602.PubMed Malde DJ, Oliveira-Cunha M, Smith AM. Pancreatic carcinoma masquerading as groove pancreatitis: case report and review of literature. Jop. 2011;12:598–602.PubMed
26.
go back to reference Tandon RK, Sato N, Garg PK. Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol. 2002;17:508–18.CrossRefPubMed Tandon RK, Sato N, Garg PK. Chronic pancreatitis: Asia-Pacific consensus report. J Gastroenterol Hepatol. 2002;17:508–18.CrossRefPubMed
27.
go back to reference Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006;38:668–73.CrossRefPubMedPubMedCentral Witt H, Sahin-Toth M, Landt O, Chen JM, Kahne T, Drenth JP, Kukor Z, Szepessy E, Halangk W, Dahm S, et al. A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet. 2006;38:668–73.CrossRefPubMedPubMedCentral
28.
go back to reference Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley RM, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2:252–61.CrossRefPubMed Howes N, Lerch MM, Greenhalf W, Stocken DD, Ellis I, Simon P, Truninger K, Ammann R, Cavallini G, Charnley RM, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2:252–61.CrossRefPubMed
29.
30.
go back to reference Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36:54–62.CrossRefPubMed Yadav D, Pitchumoni CS. Issues in hyperlipidemic pancreatitis. J Clin Gastroenterol. 2003;36:54–62.CrossRefPubMed
31.
go back to reference Bradley EL, 3rd: A clinically based classification system for acute pancreatitis. Summary of the international symposium on acute pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993, 128:586–590.CrossRefPubMed Bradley EL, 3rd: A clinically based classification system for acute pancreatitis. Summary of the international symposium on acute pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg 1993, 128:586–590.CrossRefPubMed
32.
33.
go back to reference Li BR, Liao Z, Du TT, Ye B, Zou WB, Chen H, Ji JT, Zheng ZH, Hao JF, Jiang YY, et al. Risk factors for complications of pancreatic extracorporeal shock wave lithotripsy. Endoscopy. 2014;46:1092–100.CrossRefPubMed Li BR, Liao Z, Du TT, Ye B, Zou WB, Chen H, Ji JT, Zheng ZH, Hao JF, Jiang YY, et al. Risk factors for complications of pancreatic extracorporeal shock wave lithotripsy. Endoscopy. 2014;46:1092–100.CrossRefPubMed
34.
go back to reference Sun XT, Hu LH, Xia T, Shi LL, Sun C, Du YQ, Wang W, Chen JM, Liao Z, Li ZS. Clinical features and endoscopic treatment of Chinese patients with hereditary pancreatitis. Pancreas. 2015;44:59–63.CrossRefPubMed Sun XT, Hu LH, Xia T, Shi LL, Sun C, Du YQ, Wang W, Chen JM, Liao Z, Li ZS. Clinical features and endoscopic treatment of Chinese patients with hereditary pancreatitis. Pancreas. 2015;44:59–63.CrossRefPubMed
35.
go back to reference Dumonceau JM, Delhaye M, Tringali A, Dominguez-Munoz JE, Poley JW, Arvanitaki M, Costamagna G, Costea F, Deviere J, Eisendrath P, et al. Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:784–800.CrossRefPubMed Dumonceau JM, Delhaye M, Tringali A, Dominguez-Munoz JE, Poley JW, Arvanitaki M, Costamagna G, Costea F, Deviere J, Eisendrath P, et al. Endoscopic treatment of chronic pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) clinical guideline. Endoscopy. 2012;44:784–800.CrossRefPubMed
36.
go back to reference Li BR, Liao Z, Du TT, Ye B, Chen H, Ji JT, Zheng ZH, Hao JF, Ning SB, Wang D, et al. Extracorporeal shock wave lithotripsy is a safe and effective treatment for pancreatic stones coexisting with pancreatic pseudocysts. Gastrointest Endosc. 2016;84:69–78.CrossRefPubMed Li BR, Liao Z, Du TT, Ye B, Chen H, Ji JT, Zheng ZH, Hao JF, Ning SB, Wang D, et al. Extracorporeal shock wave lithotripsy is a safe and effective treatment for pancreatic stones coexisting with pancreatic pseudocysts. Gastrointest Endosc. 2016;84:69–78.CrossRefPubMed
37.
go back to reference Schreyer AG, Jung M, Riemann JF, Niessen C, Pregler B, Grenacher L, Hoffmeister A. S3 guideline for chronic pancreatitis - diagnosis, classification and therapy for the radiologist. Rofo. 2014;186:1002–8.CrossRefPubMed Schreyer AG, Jung M, Riemann JF, Niessen C, Pregler B, Grenacher L, Hoffmeister A. S3 guideline for chronic pancreatitis - diagnosis, classification and therapy for the radiologist. Rofo. 2014;186:1002–8.CrossRefPubMed
38.
go back to reference Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2015. J Gastroenterol. 2016;51:85–92.CrossRefPubMed Ito T, Ishiguro H, Ohara H, Kamisawa T, Sakagami J, Sata N, Takeyama Y, Hirota M, Miyakawa H, Igarashi H, et al. Evidence-based clinical practice guidelines for chronic pancreatitis 2015. J Gastroenterol. 2016;51:85–92.CrossRefPubMed
39.
go back to reference Ma Y, Zhou W, He S, Xu W, Xiao J. Tyrosine kinase inhibitor sunitinib therapy is effective in the treatment of bone metastasis from cancer of unknown primary: identification of clinical and immunohistochemical biomarkers predicting survival. Int J Cancer. 2016;139:1423–30.CrossRefPubMed Ma Y, Zhou W, He S, Xu W, Xiao J. Tyrosine kinase inhibitor sunitinib therapy is effective in the treatment of bone metastasis from cancer of unknown primary: identification of clinical and immunohistochemical biomarkers predicting survival. Int J Cancer. 2016;139:1423–30.CrossRefPubMed
40.
go back to reference Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology. 1994;107:1481–7.CrossRefPubMed Layer P, Yamamoto H, Kalthoff L, Clain JE, Bakken LJ, DiMagno EP. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology. 1994;107:1481–7.CrossRefPubMed
42.
go back to reference Smith RC, Smith SF, Wilson J, Pearce C, Wray N, Vo R, Chen J, Ooi CY, Oliver M, Katz T, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 2016;16:164–80.CrossRefPubMed Smith RC, Smith SF, Wilson J, Pearce C, Wray N, Vo R, Chen J, Ooi CY, Oliver M, Katz T, et al. Summary and recommendations from the Australasian guidelines for the management of pancreatic exocrine insufficiency. Pancreatology. 2016;16:164–80.CrossRefPubMed
Metadata
Title
Risk factor for steatorrhea in pediatric chronic pancreatitis patients
Authors
Lu Hao
Teng Wang
Lin He
Ya-Wei Bi
Di Zhang
Xiang-Peng Zeng
Lei Xin
Jun Pan
Dan Wang
Jun-Tao Ji
Ting-Ting Du
Jin-Huan Lin
Li-Sheng Wang
Wen-Bin Zou
Hui Chen
Ting Xie
Hong-Lei Guo
Bai-Rong Li
Zhuan Liao
Zheng-Lei Xu
Zhao-Shen Li
Liang-Hao Hu
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2018
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-018-0902-z

Other articles of this Issue 1/2018

BMC Gastroenterology 1/2018 Go to the issue